Sonoma Pharmaceuticals, Inc. (SNOA) stock
SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)
Close on Nov 17, 2026Market cap $3.99MP/E –Yield –
Sonoma Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Sonoma Pharmaceuticals's total debt was $140.00K at Jun 30, 2026. For fiscal 2026 it was $222.00K, up 0.9% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $3.24M in fiscal 2012.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $222.00K | +0.9% |
| FY2025 | Mar 31, 2025 | $220.00K | -31.9% |
| FY2024 | Mar 31, 2024 | $323.00K | -25.1% |
| FY2023 | Mar 31, 2023 | $431.00K | – |
| FY2022 | Mar 31, 2022 | $0 | -100.0% |
| FY2021 | Mar 31, 2021 | $1.91M | +296.3% |
| FY2020 | Mar 31, 2020 | $481.00K | +44.0% |
| FY2019 | Mar 31, 2019 | $334.00K | +27.5% |
| FY2018 | Mar 31, 2018 | $262.00K | +56.0% |
| FY2017 | Mar 31, 2017 | $168.00K | +47.4% |
| FY2016 | Mar 31, 2016 | $114.00K | +31.0% |
| FY2015 | Mar 31, 2015 | $87.00K | -40.8% |
| FY2014 | Mar 31, 2014 | $147.00K | -92.4% |
| FY2013 | Mar 31, 2013 | $1.94M | -40.3% |
| FY2012 | Mar 31, 2012 | $3.24M | +27.3% |
| FY2011 | Mar 31, 2011 | $2.55M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $140.00K | +0.7% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $222.00K | +0.9% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $0 | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $56.00K | -31.7% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $139.00K | -31.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $220.00K | -31.9% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $0 | -100.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $82.00K | +446.7% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $204.00K | +1260.0% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $323.00K | +2053.3% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $431.00K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $15.00K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $15.00K | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $15.00K | -99.2% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $0 | -100.0% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $0 | -100.0% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $0 | -100.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $1.91M | +296.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $1.31M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.36M | +1182.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $1.58M | +646.4% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $481.00K | +44.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $0 | -100.0% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $106.00K | +7.1% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $211.00K | -5.4% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $334.00K | +27.5% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $22.00K | -53.2% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $99.00K | +12.5% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $223.00K | +72.9% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $262.00K | +56.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $47.00K | -21.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $88.00K | +12.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $129.00K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $168.00K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $60.00K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $78.00K | – |
See a number that looks wrong?